ici 118551 has been researched along with dopexamine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muir, WW | 1 |
| Bass, AS | 1 |
| Böhm, M; Erdmann, E; Kemkes, B; Klövekorn, WP; Pieske, B; Schnabel, P; Schwinger, R | 1 |
| Farmer, JB; Hall, JC; Simpson, WT; Smith, GW | 1 |
| Amenta, F; Cavallotti, C; Napoleone, P; Ricci, A | 1 |
| Abdul-Hussein, N; Chang, DH; Einstein, R; Matthews, R; Richardson, DP; Wong, TW | 1 |
| Gebhard, MM; Häcker, A; Martin, E; Schmidt, H; Schmidt, W | 1 |
7 other study(ies) available for ici 118551 and dopexamine
| Article | Year |
|---|---|
Inotropic mechanisms of dopexamine hydrochloride in horses.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cardiac Output; Dopamine; Dopamine Antagonists; Heart Rate; Hemodynamics; Horses; Myocardial Contraction; Propanolamines; Stimulation, Chemical; Vascular Resistance | 1992 |
Contrasting effects of dopexamine hydrochloride on electrolyte excretion in canine kidney.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Animals; Antipsychotic Agents; Benzazepines; Blood Pressure; Dogs; Dopamine; Drug Interactions; Glomerular Filtration Rate; Kidney; Male; Propanolamines; Receptors, Dopamine; Sodium | 1990 |
Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.
Topics: Adenylyl Cyclases; Adrenergic Agonists; Adrenergic beta-Antagonists; Binding, Competitive; Dopamine; Female; Heart Failure; Humans; Imidazoles; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Papillary Muscles; Propanolamines; Receptors, Adrenergic, beta | 1989 |
The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Animals; Antipsychotic Agents; Benzazepines; Dogs; Dopamine; Female; Ganglionic Blockers; Hemodynamics; Isoproterenol; Male; Propanolamines; Receptors, Adrenergic, beta; Receptors, Dopamine | 1987 |
Dopexamine hydrochloride in the human kidney: localization, receptor binding and effect on 3'-5'-cyclic adenosine monophosphate generation.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Autoradiography; Benzazepines; Binding Sites; Binding, Competitive; Cyclic AMP; Dopamine; Dopamine Agents; Humans; In Vitro Techniques; Kidney; Middle Aged; Propanolamines; Radioligand Assay; Receptors, Adrenergic, beta-2; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1993 |
Cardiovascular actions of dopexamine in anaesthetized and conscious dogs.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anesthesia; Animals; Blood Pressure; Dogs; Dopamine; Dose-Response Relationship, Drug; Heart Rate; Infusions, Intravenous; Myocardial Contraction; Pressoreceptors; Propanolamines; Raclopride; Reproducibility of Results; Salicylamides; Stimulation, Chemical | 1994 |
Dopexamine attenuates endotoxin-induced microcirculatory changes in rat mesentery: role of beta2 adrenoceptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bacteremia; Capillary Permeability; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Escherichia coli Infections; Leukocytes; Male; Mesentery; Microcirculation; Propanolamines; Random Allocation; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2; Vasodilator Agents | 1998 |